Extended release quetiapine fumarate (quetiapine XR) monotherapy in long-term treatment of generalized anxiety disorder (GAD): Efficacy and tolerability results from a randomized, placebo-controlled trial

被引：0
|
作者：
Katzman, Martin [1 ,2 ,3 ,4 ]
Brawman-Mintzer, Olga [5 ,6 ]
Reyes, Efren [7 ]
Olausson, Bengt [8 ]
Liu, Sherry [9 ]
Brecher, Martin [9 ]
机构：
[1] START Clin, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] No Ontario Sch Med, Thunder Bay, ON, Canada
[4] Lakehead Univ, Dept Psychol, Thunder Bay, ON P7B 5E1, Canada
[5] Med Univ S Carolina, Dept Psychiat & Behav Sci, N Charleston, SC USA
[6] Ralph H Johnson VA Med Ctr, N Charleston, SC USA
[7] Natl Ctr Mental Hlth, Mandaluyong City, Philippines
[8] AstraZeneca, Res & Dev, Sodertalje, Sweden
[9] AstraZeneca, Wilmington, DE USA
来源：
BIOLOGICAL PSYCHIATRY | 2008年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
435
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [21] A randomised, placebo-controlled study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 332 - 333
  • [22] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy and adjunct therapy in patients with major depressive disorder
    Kalali, A.
    Montgomery, S.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 151 - 151
  • [23] Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study
    Weisler, Richard
    Joyce, J. Mark
    McGill, Lora
    Lazarus, Arthur
    Szamosi, Johan
    Eriksson, Hans
    CNS SPECTRUMS, 2009, 14 (06) : 299 - 313
  • [24] The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study
    Gabriel, A.
    CLINICA TERAPEUTICA, 2011, 162 (02): : 113 - 118
  • [25] Double-blind study of the efficacy and tolerability of extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Earley, W.
    McIntyre, A.
    Wang, G.
    Raines, S.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 332 - 332
  • [26] Efficacy and tolerability of once-daily extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD)
    Katila, H.
    Mezhebovsky, I.
    Mulroy, A.
    Berggren, L.
    Datto, C.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 338
  • [27] Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial
    Villarreal, Gerardo
    Hamner, Mark B.
    Canive, Jose M.
    Robert, Sophie
    Calais, Lawrence A.
    Durklaski, Valerie
    Zhai, Yusheng
    Qualls, Clifford
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (12): : 1205 - 1212
  • [28] Effects of extended release Quetiapine Fumarate (Quetiapine XR) on patient-reported outcomes in patients with Generalised Anxiety Disorder (GAD)
    Svedater, H.
    Endicott, J.
    Locklear, J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 44 - 44
  • [29] Results from a phase III study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder
    Bandelow, B.
    Bobes, J.
    Ahokas, A.
    Eggens, I.
    Liu, S.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 314 - 315
  • [30] Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
    Bandelow, Borwin
    Chouinard, Guy
    Bobes, Julio
    Ahokas, Antti
    Eggens, Ivan
    Liu, Sherry
    Eriksson, Hans
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (03): : 305 - 320
12345